A Phase I Clinical Trial of Oral Suberoylanilide Hydroxamic Acid (MK-0683) in Combination with Pemetrexed and Cisplatin in Patients with Advanced Cancer
|Effective start/end date
|6/26/06 → 9/30/08
- PRA HEALTH SCIENCES
- MERCK AND CO INC
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.